BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 30659020)

  • 21. Let-7a induces metabolic reprogramming in breast cancer cells via targeting mitochondrial encoded ND4.
    Sharma P; Sharma V; Ahluwalia TS; Dogra N; Kumar S; Singh S
    Cancer Cell Int; 2021 Nov; 21(1):629. PubMed ID: 34838007
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long non-coding RNA PHACTR2-AS1 promotes tongue squamous cell carcinoma metastasis by regulating Snail.
    Yuan F; Miao Z; Chen W; Wu F; Wei C; Yong J; Xiao C
    J Biochem; 2020 Dec; 168(6):651-657. PubMed ID: 32702100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
    Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
    Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and clinical value of PD-L1 which is regulated by BRD4 in tongue squamous cell carcinoma.
    Zhao L; Li P; Zhao L; Wang M; Tong D; Meng Z; Zhang Q; Li Q; Zhang F
    J Cell Biochem; 2020 Feb; 121(2):1855-1869. PubMed ID: 31633227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial miR-181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain.
    Zhuang X; Chen Y; Wu Z; Xu Q; Chen M; Shao M; Cao X; Zhou Y; Xie M; Shi Y; Zeng Y; Bu H
    Carcinogenesis; 2020 Jul; 41(7):972-983. PubMed ID: 31628462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression analysis and function of mitochondrial genome-encoded microRNAs.
    Kuthethur R; Shukla V; Mallya S; Adiga D; Kabekkodu SP; Ramachandra L; Saxena PUP; Satyamoorthy K; Chakrabarty S
    J Cell Sci; 2022 Apr; 135(8):. PubMed ID: 35297485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-15b inhibits cancer-initiating cell phenotypes and chemoresistance of cisplatin by targeting TRIM14 in oral tongue squamous cell cancer.
    Wang X; Guo H; Yao B; Helms J
    Oncol Rep; 2017 May; 37(5):2720-2726. PubMed ID: 28350138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic modification of miR-663 controls mitochondria-to-nucleus retrograde signaling and tumor progression.
    Carden T; Singh B; Mooga V; Bajpai P; Singh KK
    J Biol Chem; 2017 Dec; 292(50):20694-20706. PubMed ID: 29066618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High SOX8 expression promotes tumor growth and predicts poor prognosis through GOLPH3 signaling in tongue squamous cell carcinoma.
    Chen S; Li H; Li X; Chen W; Zhang X; Yang Z; Chen Z; Chen J; Zhang Y; Shi D; Song M
    Cancer Med; 2020 Jun; 9(12):4274-4289. PubMed ID: 32307911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
    Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
    Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
    Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
    Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PGC1α regulates mitochondrial oxidative phosphorylation involved in cisplatin resistance in ovarian cancer cells via nucleo-mitochondrial transcriptional feedback.
    Shen L; Zhou L; Xia M; Lin N; Ma J; Dong D; Sun L
    Exp Cell Res; 2021 Jan; 398(1):112369. PubMed ID: 33220258
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LUCAT1 as an oncogene in tongue squamous cell carcinoma by targeting miR-375 expression.
    Zhang K; Wang Q; Zhong B; Gong Z
    J Cell Mol Med; 2021 May; 25(10):4543-4550. PubMed ID: 33787082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knockdown of long noncoding RNA urothelial cancer-associated 1 enhances cisplatin chemosensitivity in tongue squamous cell carcinoma cells.
    Wang J; Li L; Wu K; Ge W; Zhang Z; Gong L; Yuan D
    Pharmazie; 2016 Oct; 71(10):598-602. PubMed ID: 29441929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor.
    Li J; Huang H; Sun L; Yang M; Pan C; Chen W; Wu D; Lin Z; Zeng C; Yao Y; Zhang P; Song E
    Clin Cancer Res; 2009 Jun; 15(12):3998-4008. PubMed ID: 19509158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer.
    Okamura S; Yoshino H; Kuroshima K; Tsuruda M; Osako Y; Sakaguchi T; Yonemori M; Yamada Y; Tatarano S; Nakagawa M; Enokida H
    BMC Cancer; 2021 Jan; 21(1):48. PubMed ID: 33430801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.